SEATTLE, WA--(Marketwired - May 20, 2013) - Atossa Genetics, Inc. (
For more information about the conference or to schedule a one-on-one meeting with Atossa's management, please contact your Sidoti representative or visit www.sidoti.com .
About Atossa Genetics, Inc.
Atossa Genetics, Inc. (
The National Reference Laboratory for Breast Health (NRLBH; www.nrlbh.com ), a wholly owned subsidiary of Atossa Genetics, Inc., is a CLIA-certified high-complexity molecular diagnostic laboratory located in Seattle, WA. The NRLBH provides the patented ForeCYTE Breast Health Test, a risk assessment test for women 18 to 73 years of age akin to the Pap Smear, and the ArgusCYTE Breast Health Test, a blood test for recurrence in breast cancer survivors that provides a "liquid biopsy" for circulating breast cancer cells and a tailored treatment plan for patients and their caregivers.
Contact: Atossa Genetics, Inc. Kyle Guse Chief Financial Officer and General Counsel 800-351-3902 Email Contact Matthew D. Haines (Investors) Managing Director MBS Value Partners 212-710-9686 Email Contact